Paper Details 
Original Abstract of the Article :
A high inter-individual variation in the pharmacokinetics and pharmacodynamics of morphine has been observed. Genetic polymorphisms in genes encoding the organic cation transporter isoform 1 (OCT1), the efflux transporter p-glycoprotein (ABCB1), and the UDP-glucuronosyltransferase-2B7 (UGT2B7) may i...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.ejps.2016.12.039

データ提供:米国国立医学図書館(NLM)

Morphine Pharmacokinetics: Unraveling the Sands of Individual Variability

The world of drug metabolism is a vast and ever-changing desert, where the same drug can have different effects on different individuals. This research explores the influence of genetic variations on morphine pharmacokinetics, seeking to understand the reasons behind this variability, like trying to decipher the shifting sands of the desert. The authors aimed to evaluate the association between genetic variants in specific genes and morphine pharmacokinetics and pharmacodynamics in healthy volunteers.

A Desert of Variability: Genetic Influences on Morphine Metabolism

The study found no association between specific genetic variants in the OCT1, ABCB1, and UGT2B7 genes and morphine pharmacokinetics. This is like finding a section of the desert where the sand dunes are relatively uniform, not showing the typical variability seen in other areas. The researchers suggest that other factors may contribute to the observed variability in morphine pharmacokinetics.

Navigating the Treatment Landscape: Understanding Individual Differences

The study underscores the importance of considering individual differences in drug metabolism and response. While genetic variations may not be the primary driver of morphine pharmacokinetic variability, other factors, like age, gender, and underlying health conditions, may play a role. This is like recognizing that the desert landscape is not uniform, and different areas require different strategies for navigation. Further research is needed to fully understand the factors influencing morphine pharmacokinetics and tailor treatment to individual patients.

Dr.Camel's Conclusion

This research delves into the complex world of drug metabolism, highlighting the challenges of understanding individual variability in response to medications. While genetic variations were not found to be the primary driver of morphine pharmacokinetics, the study emphasizes the importance of considering individual differences. It's like navigating a desert landscape where the paths may shift and change depending on the time of year and the prevailing winds.

Date :
  1. Date Completed 2017-05-26
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28063968

DOI: Digital Object Identifier

10.1016/j.ejps.2016.12.039

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.